Avita Enlists Sinopharm In ReCell Sales Ramp-Up
This article was originally published in Clinica
Avita Medical has teamed up with China’s largest medical and healthcare group, to help it penetrate further into what it believes is the most strategic market – alongside the US – for its autologous cell-based therapy for advanced woundcare and skin defects.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.